Full-Time

Xenium Sales Specialist

Confirmed live in the last 24 hours

10x Genomics

10x Genomics

1,001-5,000 employees

Biotechnology tools for genomic research

Biotechnology
Healthcare

Compensation Overview

$133.7k - $180.9kAnnually

+ Equity Grants + Annual Bonus Program

Senior

Cambridge, MA, USA + 4 more

More locations: Vermont, USA | Canada | Maine, USA | Massachusetts, USA

The position requires at least 50% travel within the territory.

Category
Field Sales
Sales & Account Management
Required Skills
Sales

You match the following 10x Genomics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in Biology, Molecular Biology, Biochemistry or related field; or the equivalent knowledge and experience.
  • Minimum of 6 years sales experience in Life Science, with significant capital equipment experience.
  • Proven success in selling capital equipment.
  • Ability to travel as needed to be successful in this field-based role, expected to be at least 50% of the time within the territory.
Responsibilities
  • Demonstrates technical credibility to consult with customers on technology solutions.
  • Exceptional funnel management skills with strong hunting/prospecting and closing skills.
  • Commitment to rigorous territory planning, market knowledge, both accurate and timely forecasting.
  • Develops and manages to a business plan to meet or exceed business goals for the assigned territory.
  • Understands the scientific projects and business needs of the customer to win the business.
  • Consistently and accurately manages the sales process including sales forecasting, pipeline management, and sales tracking through the use of the CRM system and other designated IT tools.
  • Develops and maintains current knowledge of the spatial/in-situ markets, products, and buying practices required to effectively compete in the assigned territory.
  • Strong communication skills in order to keep both internal and external stakeholders informed.
  • Utilizes product and application knowledge across the in situ portfolio to successfully conduct selling presentations and close instrument and reagent sales.
  • Ability to work collaboratively with the other members of the field organization.
  • Work with distributors to drive the Xenium technology (as needed) inclusive of training and joint travel days.
  • Represent the company professionally, ethically, and morally at all times.
Desired Qualifications
  • A Master’s or PhD degree is desirable.
  • Strong desire to win business and establish long term customer relationships.

10x Genomics develops products that enhance genomic research, particularly in the life sciences sector. Their main offerings include tools for single-cell analysis, spatial gene expression, and immune profiling, which allow researchers to examine genetic information in great detail. These products help scientists understand complex biological systems and are essential for advancing personalized medicine and research capabilities. The company sells laboratory equipment, consumables like reagents and microfluidic chips, and software solutions for data analysis. Unlike many competitors, 10x Genomics focuses on high-resolution genomic data, catering to academic, clinical, and pharmaceutical researchers. Their goal is to support scientific discovery and the development of new treatments through innovative genomic tools.

Company Size

1,001-5,000

Company Stage

IPO

Total Funding

$214.9M

Headquarters

Pleasanton, California

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for personalized medicine boosts need for 10x Genomics' high-resolution tools.
  • AI integration in genomics enhances data analysis, offering development opportunities for 10x Genomics.
  • Spatial transcriptomics rise creates new market opportunities for 10x Genomics' product expansion.

What critics are saying

  • Increased competition from companies like NanoString could impact market share.
  • Recent revenue decline suggests challenges in maintaining growth momentum.
  • Ongoing legal battles may strain financial and operational resources.

What makes 10x Genomics unique

  • 10x Genomics offers cutting-edge single-cell and spatial biology solutions.
  • Their Chromium products democratize access to single-cell analysis, enhancing research capabilities.
  • The company integrates instruments, consumables, and software for comprehensive genomic analysis.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive health benefits

Generous time off

Parental leave

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
PR Newswire
Feb 18th, 2025
10X Genomics To Participate In The 45Th Annual Td Cowen Health Care Conference

PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, at 11:10 a.m. Eastern Time.Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology

PR Newswire
Jan 12th, 2025
10X Genomics Announces Preliminary Select Fourth Quarter And Full Year 2024 Results

FY 2024 revenue of ~$611 million and Q4 2024 revenue of ~$165 million, representing 9% growth sequentiallyPLEASANTON, Calif., Jan. 12, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2024.Preliminary, Unaudited Select Fourth Quarter 2024 Financial ResultsRevenue of approximately $165.0 million for the three months ended December 31, 2024 , representing 9% growth sequentially and a 10% decrease as compared to the corresponding prior year period.for the three months ended , representing 9% growth sequentially and a 10% decrease as compared to the corresponding prior year period. Instruments revenue of approximately $24.4 million , representing 28% growth sequentially and a 37% decrease as compared to the corresponding prior year period. Instruments revenue consists of approximately $10.9 million of Chromium instruments revenue and $13.4 million of Spatial instruments revenue., representing 28% growth sequentially and a 37% decrease as compared to the corresponding prior year period. Instruments revenue consists of approximately of Chromium instruments revenue and of Spatial instruments revenue

Securities.io
Jan 7th, 2025
Can Ai Predict One’S Metabolomic Age And Tailor Health Plans Accordingly?

Artificial intelligence continues to push the boundaries of science and health exploration. From mapping proteins to neurological networks, these systems continue to make game-changing impacts on the sector. This month, a group of advantageous researchers from the Institute of Psychiatry, Psychology & Neuroscience took AI integration further. They released a study in which AI algorithms were used to predict the metabolic age of patients. Here's what you need to know.Chronological Clock vs Biological ClockTo grasp the importance of this development, it's vital to understand the differences between your chronological and biological age. These two methods of determining the age of your body are used in different ways by healthcare professionals

PR Newswire
Jan 2nd, 2025
10X Genomics To Present At The 43Rd Annual J.P. Morgan Healthcare Conference

PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time.Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health

Stock Titan
Jan 2nd, 2025
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ - 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time.